May 6, 2015

Perrigo Animal Health introduces CosequinDS national brand equivalent in Walmart. 

April 21, 2015

Teva Pharmaceutical on Tuesday made a move for Mylan in a $40 billion deal barring Mylan's proposed acquisition of Perrigo. 

January 12, 2015

Perrigo Co. on Monday announced the launch of testosterone gel 1%, the therapeutic equivalent to Androgel 1% from AbbVie. 

January 24, 2014

Perrigo announced that it received final approval from the Food and Drug Administration for repaglinide tablets — a generic version of Prandin tablets.

November 22, 2013

The shareholders of Elan Corp. approved the acquisition of the company by Perrigo Co. at two special meetings.

September 23, 2013

The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

September 20, 2013

Perrigo Co. has hired a former Food and Drug Administration official for its regulatory department, the drug maker said.

August 12, 2013

Perrigo Co. announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug applications for fluocinolone acetonide scalp oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Scalp Oil, and fluocinolone acetonide topical oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Body Oil.

August 12, 2013

Teva Pharmaceutical and Perrigo Co. announced the launch of the generic equivalent to Temodar (temozolomide). Teva will manufacture, market and distribute the product in the United States, and both companies will equally share in the cost and profitability of the product in the country.

July 29, 2013

U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.

July 19, 2013

Perrigo announced the tentative approval for repaglinide tablets, a generic version of Novo Nordisk's Prandin, used to treat Type 2 diabetes.

June 17, 2013

Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said.

May 29, 2013

The Food and Drug Administration has approved a generic drug for incontinence made by Perrigo Co., the drug maker said.

April 1, 2013

Perrigo Co. has completed its acquisition of a Pennsylvania-based animal health company, the drug maker said.

February 4, 2013

Drug maker Perrigo has launched a generic drug for treating problems of the scalp, the company said.

November 28, 2012

The Food and Drug Administration has approved a drug from Perrigo and Cobrek Pharmaceuticals for treating scalp conditions.

September 7, 2012

Perrigo is seeking regulatory approval for what it called the first generic version of a drug for treating bronchospasm.

August 8, 2012

The Food and Drug Administration has approved an oral painkiller made by Perrigo, the drug maker said Wednesday.

June 27, 2012

The Food and Drug Administration has approved an acne treatment made by Perrigo, the drug maker said Wednesday.

June 7, 2012

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

May 23, 2012

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

March 2, 2012

Perrigo announced that it has initiated market launch and made its first shipments of minoxidil 5% foam, which is a generic version of Rogaine 5% foam hair regrowth treatment, to its retail and wholesale customers. Minoxidil 5% foam is marketed under store- or own-label brands.

January 23, 2012

Perrigo is seeking approval from the Food and Drug Administration for a drug used to treat allergies in adolescents and adults, the company said Monday.